Japan has taken a groundbreaking leap in biotech by developing an artificial womb that can sustain embryo growth outside the body.

Known as EVE (Ex Vivo Uterine Environment), the system mimics a real womb to support extremely premature infants.

Still experimental, this innovation could revolutionize neonatal care, offering hope for fragile newborns while raising major medical and ethical questions for the future.